INVO (INVO Bio) רווחיות מכירות לפי רווח גולמי

The innovative INVOcell method makes IVF more accessible by allowing embryos to develop within the mother's body. The gross margin percentage demonstrates current operational efficiency, where 34.20 becomes the new value for this metric. The expansion of the clinic network offsets debt risks, while an ethical corporate culture and a focus on reproductive specialists ensure stability within the niche segment of specialized medical equipment for INVO Bioscience, Inc. (INVO).
פילוחי מדדים מקיפים ואנליטיקה עבור INVO Bio (INVO)

The business model of INVO Bioscience, Inc. (INVO) is based on the sale of high-cost equipment and high-margin consumables for IVF systems. By analyzing the gross profit margin, an investor can see the efficiency of managing direct production costs. This metric is calculated as the share of revenue minus the cost of goods sold, which allows for an assessment of the company's pricing power and the stability of its operating profit.